Forte Biosciences, Inc. - Common Stock (FBRX)
CUSIP: 34962G208
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 12,506,886
- Total 13F shares
- 736,630
- Share change
- +729,819
- Total reported value
- $4,120,236
- Price per share
- $5.59
- Number of holders
- 23
- Value change
- +$4,082,162
- Number of buys
- 21
Quarterly Holders Quick Answers
What is CUSIP 34962G208?
CUSIP 34962G208 identifies FBRX - Forte Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q4 2024
Recent filing periods for CUSIP 34962G208:
Top shareholders of FBRX - Forte Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13F
|
Company |
56%
|
3,624,548
|
$1,946,383 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
50%
|
3,265,359
|
$1,753,498 | — | 30 Jun 2024 | |
| BVF INC/IL |
13F
|
Company |
46%
|
2,982,105
|
$1,601,390 | — | 30 Jun 2024 | |
| Cable Car Capital, LP |
13F
|
Company |
31%
|
2,031,987
|
$1,091,177 | — | 30 Jun 2024 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
28%
|
1,838,965
|
$987,524 | — | 30 Jun 2024 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
28%
|
1,810,455
|
$972,214 | — | 30 Jun 2024 | |
| BML Capital Management, LLC |
13F
|
Company |
27%
|
1,761,702
|
$946,034 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
665,230
|
$357,228 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.3%
|
346,292
|
$186,008 | — | 30 Jun 2024 | |
| Hubert C. Chen |
3/4/5
|
President and Chief Scientific Officer |
—
mixed-class rows
|
183,405
mixed-class rows
|
$150,704 | — | 01 Jan 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.7%
|
174,858
|
$93,899 | — | 30 Jun 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
2.4%
|
159,258
|
$85,522 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.1%
|
133,400
|
$71,636 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.63%
|
40,811
|
$21,916 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.58%
|
37,564
|
$20,172 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.53%
|
34,344
|
$18,443 | — | 30 Jun 2024 | |
| Sanctuary Advisors, LLC |
13F
|
Company |
0.34%
|
22,014
|
$15,769 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.41%
|
26,817
|
$14,401 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.37%
|
24,310
|
$13,055 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.32%
|
20,776
|
$11,157 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.24%
|
15,798
|
$8,484 | — | 30 Jun 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.22%
|
14,017
|
$7,527 | — | 30 Jun 2024 | |
| Aries Wealth Management |
13F
|
Company |
0.2%
|
13,000
|
$6,981 | — | 30 Jun 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.17%
|
10,745
|
$5,888 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.12%
|
8,097
|
$4,348 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
3,804
|
$2,043 | — | 30 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.02%
|
1,080
|
$582 | — | 30 Jun 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.01%
|
453
|
$243 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
265
|
$142 | — | 30 Jun 2024 | |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA |
13F
|
Company |
0%
|
193
|
$112 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
128
|
$69 | — | 30 Jun 2024 | |
| REAP Financial Group, LLC |
13F
|
Company |
0%
|
97
|
$52 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
17
|
$9 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
3
|
$2 | — | 30 Jun 2024 | |
| Donald Allen Williams |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 20 Aug 2024 | |
| Lawrence Eichenfield |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 20 Aug 2024 | |
| Patricia S. Walker |
3/4/5
|
Director |
—
class O/S missing
|
25,000
|
— | — | 01 Jun 2022 |
Institutional Holders of Forte Biosciences, Inc. - Common Stock (FBRX) as of Q3 2024
As of 30 Sep 2024,
Forte Biosciences, Inc. - Common Stock (FBRX) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
736,630 shares.
The largest 10 holders included
TYBOURNE CAPITAL MANAGEMENT (HK) LTD, BVF INC/IL, PERCEPTIVE ADVISORS LLC, FRED ALGER MANAGEMENT, LLC, Cable Car Capital LLC, FARALLON CAPITAL MANAGEMENT LLC, BML Capital Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
24
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q3 2025 Across Filers
Q3 2025 holders
42
Q3 2024 holders
23
Holder diff
-19
| Investor | Q3 2025 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.